Psychedelic Stock Gainers And Losers From September 6, 2022
GAINERS:
Numinus Wellness (OTC:NUMIF) shares closed up 11.90% at $0.30
LOSERS:
Unions Make Inroads In Cannabis Industry With Latest Dispensary Joining The Ranks
Workers at the Trulieve (OTCQX: TCNNF) North Shore medical cannabis dispensary have voted to join Local 1776.
Most, But Not All, Psychedelics Companies Have Sufficient Liquidity
The Chart represents the liquidity positions of the 21 Psychedelic sector companies in the Viridian Value Tracker database.
CordovaCann’s Star Buds Cannabis Hits Record Monthly Revenue Of 1.26M In August
CordovaCann Corp. (OTCQB: LVRLF) (CSE:CDVA), a cannabis-focused consumer products company, provided an update on its Star Buds Cannabis Co. retail operations in Canada.
Harvest One Announces Effective Date Of Name Change To Delivra Health Brands
TSX Venture Exchange has conditionally approved the name change of Harvest One Cannabis Inc. (OTCQB: HRVOF) (TSXV:HVT) to "Delivra Health Brands Inc.".
Icanic Appoints New CEO
Icanic Brands Company Inc. (OTCQB: ICNAF) (CSE:ICAN), appointed Micah Anderson to the position of CEO of the company.
Elon Musk: Henry Ford Did It, You Can Too, Hemp’s Myriad Uses Including Cars, Fuel, Textiles & Beer!
As so often reported, hemp-based CBD has numerous uses in the development of medicines for a variety of conditions and illnesses.
But with Labor Day upon us, how about we look at some of the practical uses of hemp?
What Do You Do With Five Hundred Tons Of Surplus Weed? Cannabis Producers Have An Oversupply Problem
When Canada became the second country in the world, after Uruguay, to legalize cannabis, weed companies were viewed as pioneers in “the green frontier.” Their stocks and their fortunes soared. They suddenly became rock stars.
Marijuana Research Focuses Strictly On Potential Harms From THC, NCCIH Director Says
Director of the National Center for Complementary and Integrative Health (NCCIH)
Bearish Sentiment Across The Cannabis Space – Check Full Movers For September 2, 2022
GAINERS:
Cipher Pharmaceuticals (OTC:CPHRF) shares closed up 6.60% at $2.10